# ClinicalTrials.gov record NCT01430195

> PeptideScanner retained ClinicalTrials.gov record NCT01430195 at 2026-07-30T21:55:56.618Z. Its registry update date was 2013-03-22, and PeptideScanner's reviewed identity mapping was afamelanotide.

- Evidence object: `story:clinicaltrials-gov-nct01430195-afamelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2013-03-22
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01430195-afamelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01430195-afamelanotide-v1.json
- Content SHA-256: `0ad2261a6e1b9dee62a3f25255732893939e6dd86fdb52a45645c13092aa2d1a`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01430195 ([`ctg-observation-nct01430195-2013-03-22-1368ef06b8d7`](#source-ctg-observation-nct01430195-2013-03-22-1368ef06b8d7))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01430195 at 2026-07-30T21:55:56.618Z. Its registry update date was 2013-03-22, and PeptideScanner's reviewed identity mapping was afamelanotide. ([`ctg-observation-nct01430195-2013-03-22-1368ef06b8d7`](#source-ctg-observation-nct01430195-2013-03-22-1368ef06b8d7))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01430195 at 2026-07-30T21:55:56.618Z. Its registry update date was 2013-03-22, and PeptideScanner's reviewed identity mapping was afamelanotide. ([`ctg-observation-nct01430195-2013-03-22-1368ef06b8d7`](#source-ctg-observation-nct01430195-2013-03-22-1368ef06b8d7))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01430195-2013-03-22-1368ef06b8d7`](#source-ctg-observation-nct01430195-2013-03-22-1368ef06b8d7))

## Sources

<a id="source-ctg-observation-nct01430195-2013-03-22-1368ef06b8d7"></a>
- **ClinicalTrials.gov record NCT01430195 · retained source version 2013-03-22:1368ef06b8d7551d13f068208ccb2ca1a79afa00cfb1aac094b5b530f4272fc0** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01430195) (`ctg-observation-nct01430195-2013-03-22-1368ef06b8d7`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01430195." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01430195-afamelanotide-v1.json SHA-256: 0ad2261a6e1b9dee62a3f25255732893939e6dd86fdb52a45645c13092aa2d1a.